Advanced search
1 file | 138.43 KB

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study

(2010) JOURNAL OF CLINICAL ONCOLOGY. 28(29). p.4450-4456
Author
Organization
Keywords
CHEMORADIATION, PANCREATICODUODENECTOMY, LONG-TERM SURVIVAL, NUCLEOSIDE TRANSPORTER 1, CONCURRENT RADIATION, CONTROLLED-TRIAL, HEAD CARCINOMA, ADENOCARCINOMA, CHEMOTHERAPY, RADIOTHERAPY

Downloads

    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 138.43 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Van Laethem, Jean-Luc, Pascal Hammel, Françoise Mornex, David Azria, Geertjan Van Tienhoven, Philippe Vergauwe, Marc Peeters, et al. 2010. “Adjuvant Gemcitabine Alone Versus Gemcitabine-based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: a Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study.” Journal of Clinical Oncology 28 (29): 4450–4456.
APA
Van Laethem, J.-L., Hammel, P., Mornex, F., Azria, D., Van Tienhoven, G., Vergauwe, P., Peeters, M., et al. (2010). Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. JOURNAL OF CLINICAL ONCOLOGY, 28(29), 4450–4456.
Vancouver
1.
Van Laethem J-L, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. JOURNAL OF CLINICAL ONCOLOGY. 2010;28(29):4450–6.
MLA
Van Laethem, Jean-Luc, Pascal Hammel, Françoise Mornex, et al. “Adjuvant Gemcitabine Alone Versus Gemcitabine-based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: a Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study.” JOURNAL OF CLINICAL ONCOLOGY 28.29 (2010): 4450–4456. Print.
@article{1193713,
  author       = {Van Laethem, Jean-Luc and Hammel, Pascal and Mornex, Fran\c{c}oise and Azria, David and Van Tienhoven, Geertjan and Vergauwe, Philippe and Peeters, Marc and Polus, Marc and Praet, Marleen and Mauer, Murielle and Collette, Laurence and Budach, Volker and Lutz, Manfred and Van Cutsem, Eric and Haustermans, Karin},
  issn         = {0732-183X},
  journal      = {JOURNAL OF CLINICAL ONCOLOGY},
  keyword      = {CHEMORADIATION,PANCREATICODUODENECTOMY,LONG-TERM SURVIVAL,NUCLEOSIDE TRANSPORTER 1,CONCURRENT RADIATION,CONTROLLED-TRIAL,HEAD CARCINOMA,ADENOCARCINOMA,CHEMOTHERAPY,RADIOTHERAPY},
  language     = {eng},
  number       = {29},
  pages        = {4450--4456},
  title        = {Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study},
  url          = {http://dx.doi.org/10.1200/JCO.2010.30.3446},
  volume       = {28},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: